Breaking News, Promotions & Moves

PDI, Inc.

Richard P. Micali has been appointed senior vice president of sales services, PDI, Inc. Mr. Micali spent the last 25 years of his career at Bristol-Myers Squibb, where he most recently served as vice president, sales and led the U.S. national sales force in the oncology division, where Eribitux was successfully launched.

Mr. Micali has experience in sales, marketing and managed markets. He began his career as a sales representative in 1983 and has held positions of increasing responsibility including district sales manager, vice president, and regional vice president, where he led the company’s largest primary care sales region. During his tenure with BMS, he also collaborated with partners such as Novartis, Sanofi-Aventis, ImClone and Schering-Plough on the sale of several biopharmaceutical products. 

“Rich brings many years of leadership experience in building, developing, and retaining high-performance sales teams,” said Nancy Lurker, chief executive officer of PDI. “He is a highly regarded professional, with extensive experience in commercializing both pharmaceutical and biologic drugs, and has excellent knowledge of both specialty and primary care physicians as well as the biopharmaceutical industry in general. [In his new role] Rich will lead PDI’s Sales Services segment, which will include oversight of the company’s sales operations and training, sales data management and reporting, as well as our Talent Acquisition service offering. This will create a team appropriately aligned to drive sales effectiveness and process efficiencies. We are thrilled that Rich has joined PDI,” Ms. Lurker added.

Mr. Micali is replacing Nancy Connelly, who will stay on during an interim transition period. Commenting on Ms. Connelly’s departure, Ms. Lurker said, “We are very appreciative of Nancy’s many years of dedicated service to PDI and her contributions over the last 16 years.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters